Humanigen Announces Revised Time for Presentation at Jefferies London Healthcare Conference

Humanigen, Inc. (Nasdaq: HGEN) (Humanigen), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called cytokine storm, announced that its presentation time at the Jefferies London Healthcare Conference has been changed.